Jundishapur Journal of Health Sciences

Jundishapur Journal of Health Sciences

The Silent Crisis of Metabolic Syndrome and the Need to Reconsider Public Health Strategies in Iran: A Policy Brief

Document Type : Brief Report

Authors
1 Hearing Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2 Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3 Nutrition and Metabolic Diseases Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4 Department of Internal Medicine, Osh State University, Osh, Kyrgyzstan
Abstract
Background and Objective: Research problem: Metabolic syndrome (MetS) is a major driver of cardiovascular disease and type 2 diabetes. It can be considered a serious threat to public health. Evidence from Iran indicates a growing prevalence that threatens both population health and economic stability.
 
Methods: This policy brief is based on findings from a study titled “Socioeconomic status and metabolic syndrome in Southwest Iran: Results from the Hoveyzeh Cohort Study (HCS)”.
 
Findings: The overall prevalence of MetS in the participants was 39.1%. While skill level and the Townsend index were significantly and independently associated with MetS, no such associations were observed for educational level or wealth status.
 
Conclusion: The results of our study showed that socioeconomic status (SES) is a significant factor in the prevalence of MetS. Among the four assessed SES indicators, skilled levels and Townsend score showed the strongest associations with MetS. Therefore, we recommend that interventional programs for MetS account for SES when being designed for similar communities.
 
Keywords

1-       World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2021 global survey. Geneva: World Health Organization; 2023.
2-       Saki N, Hashemi SJ, Hosseini SA, Rahimi Z, Rahim F, Cheraghian B. Socioeconomic status and metabolic syndrome in Southwest Iran: results from Hoveyzeh Cohort Study (HCS). BMC Endocr Disord.2022;22(1):332.http://doi.org/ 10.1186/s12902-022-01255-5.  [PMID]
3-       Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A, Kh F. Prevalence of metabolic syndrome in Middle-East countries: meta-analysis of cross-sectional studies. Diabetes MetabSyndr.2018;12(2):195–201.http://doi.org/ 10.1016/j.dsx.2017.11.004. [PMID]
4-       Kondo K. Social determinants of health in non-communicable diseases: case studies from Japan. Singapore: Springer Nature; 2020.http://doi.org/ 10.1007/978-981-15-1831-7.
5-       Ghaemi F, Hedayati F, Esteghamati A, Peysepar R, Deravi N, Meysamie A. Trends of metabolic syndrome among Iranian patients with diabetes and its association with cardiovascular disease and diabetes complications: a nationwide study of the National Program for Prevention and Control of Diabetes. BMC Endocr Disord. 2025;25(1):1–11.http://doi.org/ 10.1186/s12902-025-02050-8. [PMID]
6-       Farzadfar F, Yousefi M, Jafari-Khounigh A, Khorrami Z, Haghdoost A, Shadmani FK. Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030. Sci Rep. 2024;14(1):8092.http://doi.org/ 10.1038/s41598-024-58629-z. [PMID]
7-       Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647–655.http://doi.org/ 10.1093/aje/kwx314. [PMID]
8-       Cheraghian B, Hashemi SJ, Hosseini SA, Poustchi H, Rahimi Z, Sarvandian S, et al. Cohort profile: the Hoveyzeh Cohort Study (HCS): a prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran. Med J Islam Repub Iran. 2020;34:141.http://doi.org/ 10.34171/mjiri.34.141. [PMID]
9-       Negarandeh R, Kamran A, Heydari H. Iran’s health system performance in achieving goals based on the World Health Organization’s framework: a scoping review. J Res Health. 2022;12(2):65–74.http://doi.org/ 10.32598/JRH.12.2.1932.1.